GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | January 22, 2025 |
PDB ID ▲ | UniProt ID | Title | Descriptor |
---|---|---|---|
7LKF | A0A3Q3ANV4 | WT Chicken Scap L1-L7 / Fab 4G10 complex focused refinement | |
7LKF | 7LKF | WT Chicken Scap L1-L7 / Fab 4G10 complex focused refinement | |
7LKH | A0A3Q3ANV4 | Chicken Scap D435V L1-L7 domain / Fab complex focused map | |
7LKH | 7LKH | Chicken Scap D435V L1-L7 domain / Fab complex focused map | |
7LKP | P78363 | Structure of ATP-free human ABCA4 | |
7LKZ | P78363 | Structure of ATP-bound human ABCA4 | |
7LL1 | Q2N0S6 | Cryo-EM structure of BG505 DS-SOSIP in complex with glycan276-dependent broadly neutralizing antibody VRC40.01 Fab | |
7LL1 | Q2N0S7 | Cryo-EM structure of BG505 DS-SOSIP in complex with glycan276-dependent broadly neutralizing antibody VRC40.01 Fab | |
7LL1 | 7LL1 | Cryo-EM structure of BG505 DS-SOSIP in complex with glycan276-dependent broadly neutralizing antibody VRC40.01 Fab | |
7LL2 | Q2N0S6 | Cryo-EM structure of BG505 DS-SOSIP in complex with Glycan276-Dependent Broadly Neutralizing Antibody VRC33.01 Fab | |
7LL2 | Q2N0S7 | Cryo-EM structure of BG505 DS-SOSIP in complex with Glycan276-Dependent Broadly Neutralizing Antibody VRC33.01 Fab | |
7LL2 | 7LL2 | Cryo-EM structure of BG505 DS-SOSIP in complex with Glycan276-Dependent Broadly Neutralizing Antibody VRC33.01 Fab | |
7LLK | O55774 | Cryo-EM structure of Q23.17_DS-SOSIP in complex with Glycan276-Dependent Broadly Neutralizing Antibody 179NC75 Fab | |
7LLK | 7LLK | Cryo-EM structure of Q23.17_DS-SOSIP in complex with Glycan276-Dependent Broadly Neutralizing Antibody 179NC75 Fab | |
7LM8 | P0DTC2 | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with two cross-neutralizing antibodies CV38-142 and COVA1-16 Fabs isolated from COVID-19 patients | |
7LM8 | 7LM8 | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with two cross-neutralizing antibodies CV38-142 and COVA1-16 Fabs isolated from COVID-19 patients | |
7LM9 | D2E265 | Crystal structure of SARS-CoV spike protein receptor-binding domain in complex with a cross-neutralizing antibody CV38-142 Fab isolated from COVID-19 patient | |
7LM9 | 7LM9 | Crystal structure of SARS-CoV spike protein receptor-binding domain in complex with a cross-neutralizing antibody CV38-142 Fab isolated from COVID-19 patient | |
7LO4 | Q9BYF1 | SARS-CoV-2 spike receptor-binding domain with a G485R mutation in complex with human ACE2 | |
7LO4 | P0DTC2 | SARS-CoV-2 spike receptor-binding domain with a G485R mutation in complex with human ACE2 | |
7LO6 | Q2N0S6 | Structure of CD4 mimetic BNM-III-170 in complex with BG505 SOSIP.664 HIV-1 Env trimer and 17b Fab | |
7LO6 | 7LO6 | Structure of CD4 mimetic BNM-III-170 in complex with BG505 SOSIP.664 HIV-1 Env trimer and 17b Fab | |
7LOK | Q2N0S6 | Structure of CD4 mimetic M48U1 in complex with BG505 SOSIP.664 HIV-1 Env trimer and 17b Fab | Envelope Glycoprotein BG505 SOSIP.664 gp41, Envelope glycoprotein BG505 SOSIP.664 gp120, 17b Fab Light Chain, 17b Fab Heavy Chain, M48U1 |
7LOK | 7LOK | Structure of CD4 mimetic M48U1 in complex with BG505 SOSIP.664 HIV-1 Env trimer and 17b Fab | Envelope Glycoprotein BG505 SOSIP.664 gp41, Envelope glycoprotein BG505 SOSIP.664 gp120, 17b Fab Light Chain, 17b Fab Heavy Chain, M48U1 |
7LOP | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CV05-163 and CR3022 | |
7LOP | 7LOP | Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CV05-163 and CR3022 | |
7LPN | Q2N0S6 | Cryo-EM structure of llama J3 VHH antibody in complex with HIV-1 Env BG505 DS-SOSIP.664 | |
7LPN | 7LPN | Cryo-EM structure of llama J3 VHH antibody in complex with HIV-1 Env BG505 DS-SOSIP.664 | |
7LQ7 | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CV503 and COVA1-16 | |
7LQ7 | 7LQ7 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CV503 and COVA1-16 | |
7LQJ | O67854 | Crystal structure of LeuT bound to L-Alanine | |
7LQK | O67854 | Crystal structure of the R375A mutant of LeuT | |
7LQL | O67854 | Crystal structure of the R375D mutant of LeuT | |
7LQV | P0DTC2 | Cryo-EM structure of NTD-directed neutralizing antibody 4-8 Fab in complex with SARS-CoV-2 S2P spike | |
7LQV | 7LQV | Cryo-EM structure of NTD-directed neutralizing antibody 4-8 Fab in complex with SARS-CoV-2 S2P spike | |
7LQW | P0DTC2 | Cryo-EM structure of NTD-directed neutralizing antibody 2-17 Fab in complex with SARS-CoV-2 S2P spike | |
7LQW | 7LQW | Cryo-EM structure of NTD-directed neutralizing antibody 2-17 Fab in complex with SARS-CoV-2 S2P spike | |
7LR2 | C2GY91 | Crystal structure of GH5_18 from Bifidobacterium longum subsp. longum ATCC 55813 in complex with GlcNAc | |
7LR6 | C2GY91 | Crystal structure of GH5_18-E140A from Bifidobacterium longum subsp. longum ATCC 55813 in complex with Manb1-4GlcNAc | |
7LR7 | F8JJ04 | Crystal structure of GH5_18 from Streptomyces cattleya in complex with GlcNAc | |
7LR8 | F8JJ04 | Crystal structure of GH5_18-E153A from Streptomyces cattleya in complex with Manb1-4GlcNAc | |
7LRF | Q90922 | Netrin-1 in complex with SOS | |
7LRM | P03366 | Structure of HIV-1 Reverse Transcriptase in complex with DNA, dCTP, and CA(2+) ion | |
7LRS | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody A23-58.1 that targets the receptor-binding domain | |
7LRS | 7LRS | Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody A23-58.1 that targets the receptor-binding domain | |
7LRT | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody A23-58.1 that targets the receptor-binding domain | |
7LRT | 7LRT | Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody A23-58.1 that targets the receptor-binding domain | |
7LRX | P03366 | Structure of HIV-1 Reverse Transcriptase in complex with DNA, L-dCTP, and CA(2+) ion | |
7LRY | P03366 | Structure of HIV-1 Reverse Transcriptase in complex with DNA, (-)FTC-TP, and CA(2+) ion | |
7LS0 | Q6UX46 | Structure of the Human ALK GRD bound to AUG |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024